Dear study participants,
I wanted to share an experience that I had today. I had a wonderful conversation with a woman who participated in the first MiraKind study. While I always enjoy speaking with study participants, I had very mixed emotions about this conversation, because I was discussing her KRAS-variant results with her – and she is positive.
The very hard part of the conversation is that this woman has recently been diagnosed with advanced ovarian cancer. She is a 10 year + survivor of her breast cancer, and now is dealing with this. I struggled with the fact that things may have been different if she knew that she was KRAS-variant positive sooner… maybe her doctor would have followed her more closely, maybe she would have picked up a concerning symptom if she was on the look out.
Please consider getting your KRAS-variant results, especially if you have been previously diagnosed with cancer. KRAS-variant patients are at a significantly elevated risk of a second cancer, either breast or ovarian. 50% of women with both breast and ovarian cancer that are BRCA negative have the KRAS-variant, and there is up to a 16 fold increased risk of a second breast cancer after the first. If you can not afford the testing fee, ask for financial assistance, you will get it.